These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 1282590)
21. Comparison of guinea-pig ventricular myocytes and dog Purkinje fibres for in vitro assessment of drug-induced delayed repolarization. Terrar DA; Wilson CM; Graham SG; Bryant SM; Heath BM J Pharmacol Toxicol Methods; 2007; 56(2):171-85. PubMed ID: 17596973 [TBL] [Abstract][Full Text] [Related]
23. Electrophysiological effects of dofetilide in an in vitro model of "border zone" between normal and ischemic/reperfused myocardium. Rouet R; Picard S; Libersa C; Ghadanfar M; Alabaster C; Gérard JL Circulation; 2000 Jan 4-11; 101(1):86-93. PubMed ID: 10618309 [TBL] [Abstract][Full Text] [Related]
24. Hemodynamic effects of antiarrhythmic compounds: intrinsic effects and autonomic modulation. Hoffmeister HM; Beyer ME; Seipel L Am J Cardiol; 1997 Oct; 80(8A):24G-30G. PubMed ID: 9354409 [TBL] [Abstract][Full Text] [Related]
25. The cellular electrophysiologic effect of a new amiodarone like antiarrhythmic drug GYKI 16638 in undiseased human ventricular muscle: comparison with sotalol and mexiletine. Opincariu M; Varró A; Iost N; Virág L; Hála O; Szolnoki J; Szécsi J; Bogáts G; Szenohradszky P; Mátyus P; Papp JG Curr Med Chem; 2002 Jan; 9(1):41-6. PubMed ID: 11860346 [TBL] [Abstract][Full Text] [Related]
26. UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells. Gwilt M; Arrowsmith JE; Blackburn KJ; Burges RA; Cross PE; Dalrymple HW; Higgins AJ J Pharmacol Exp Ther; 1991 Jan; 256(1):318-24. PubMed ID: 1988662 [TBL] [Abstract][Full Text] [Related]
28. Effects of sematilide, a novel class III antiarrhythmic agent, on action potential in guinea pig atrium. Ishii Y; Muraki K; Kurihara A; Imaizumi Y; Watanabe M Jpn J Pharmacol; 1995 Jun; 68(2):175-82. PubMed ID: 7563974 [TBL] [Abstract][Full Text] [Related]
29. Voltage dependence of cardiac delayed rectifier block by methanesulfonamide class III antiarrhythmic agents. Krafte DS; Volberg WA J Cardiovasc Pharmacol; 1994 Jan; 23(1):37-41. PubMed ID: 7511733 [TBL] [Abstract][Full Text] [Related]
30. Effects of 5-(N,N-hexamethylene)amiloride on action potentials, intracellular Na, and pH of guinea pig ventricular muscle in vitro. Lai ZF; Hotokebuchi N; Cragoe EJ; Nishi K J Cardiovasc Pharmacol; 1994 Feb; 23(2):259-67. PubMed ID: 7511756 [TBL] [Abstract][Full Text] [Related]
31. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide. Jurkiewicz NK; Sanguinetti MC Circ Res; 1993 Jan; 72(1):75-83. PubMed ID: 8417848 [TBL] [Abstract][Full Text] [Related]
32. Effects of dofetilide and EGIS-7229, an antiarrhythmic agent possessing class III, IV, and IB activities, on myocardial refractoriness in hyperkalemia, hypokalemia, and during beta-adrenergic activation in the rabbit papillary muscle in vitro. Kovács A; Szénási G J Pharmacol Sci; 2006 Apr; 100(4):303-9. PubMed ID: 16603803 [TBL] [Abstract][Full Text] [Related]
33. Dofetilide enhances the contractility of rat ventricular myocytes via augmentation of Na+-Ca 2+ exchange. Zhang XP; Wu BW; Yang CH; Wang J; Niu SC; Zhang MS Cardiovasc Drugs Ther; 2009 Jun; 23(3):207-14. PubMed ID: 19221884 [TBL] [Abstract][Full Text] [Related]
34. Effects of the antiarrhythmic drug dofetilide on transmural dispersion of repolarization in ventriculum. A computer modeling study. Saiz J; Gomis-Tena J; Monserrat M; Ferrero JM; Cardona K; Chorro J IEEE Trans Biomed Eng; 2011 Jan; 58(1):43-53. PubMed ID: 20851784 [TBL] [Abstract][Full Text] [Related]
35. Differential class III antiarrhythmic effects of ambasilide and dofetilide at different extracellular potassium and pacing frequencies. Gjini V; Korth M; Schreieck J; Weyerbrock S; Schömig A; Schmitt C J Cardiovasc Pharmacol; 1996 Aug; 28(2):314-20. PubMed ID: 8856489 [TBL] [Abstract][Full Text] [Related]
36. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations. Chang GJ; Su MJ; Kuo SC; Lin TP; Lee YS J Pharmacol Exp Ther; 2006 Jan; 316(1):380-91. PubMed ID: 16174797 [TBL] [Abstract][Full Text] [Related]
37. Effects of MDL 11,939 on action potential and contractile force in cardiac tissues: a comparison with bretylium, clofilium, and sotalol. Li T; Carr AA; Dage RC J Cardiovasc Pharmacol; 1990 Dec; 16(6):917-23. PubMed ID: 1704984 [TBL] [Abstract][Full Text] [Related]
38. Bepridil prolongs the action potential duration of guinea pig ventricular muscle only at rapid rates of stimulation. Nobe S; Aomine M; Arita M Gen Pharmacol; 1993 Sep; 24(5):1187-96. PubMed ID: 8270178 [TBL] [Abstract][Full Text] [Related]
39. Evidence for inhibition by ICS 205-930 and stimulation by BRL 34915 of K+ conductance in cardiac muscle. Scholtysik G Naunyn Schmiedebergs Arch Pharmacol; 1987 Jun; 335(6):692-6. PubMed ID: 2442630 [TBL] [Abstract][Full Text] [Related]
40. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data. Walker DK; Alabaster CT; Congrave GS; Hargreaves MB; Hyland R; Jones BC; Reed LJ; Smith DA Drug Metab Dispos; 1996 Apr; 24(4):447-55. PubMed ID: 8801060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]